Enhancing exposure therapy for anxiety disorders with glucocorticoids: From basic mechanisms of emotional learning to clinical applications

Journal of Anxiety Disorders

Volumn 24, Issue 2, 2010, Pages 223-230

  Bentz, Dorothée ^a,b   Michael, Tanja ^a   de Quervain, Dominique J F ^b   Wilhelm, Frank H ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Faculty of Medicine   (Switzerland)

Author keywords

Anxiety disorders; Cognitive enhancer; Cognitive behavioral therapy; Cortisol; Extinction memory; Fear conditioning

Indexed keywords

ANXIOLYTIC AGENT; CORTISONE; CYCLOSERINE; GLUCOCORTICOID; HYDROCORTISONE; METYRAPONE; PLACEBO; PSYCHOTROPIC AGENT;

ANXIETY DISORDER; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CONDITIONING; DOSE RESPONSE; DRUG MECHANISM; DRUG PENETRATION; DRUG PROTEIN BINDING; EMOTION; EXPOSURE THERAPY; FEAR; HUMAN; LEARNING; LONG TERM MEMORY; LOW DRUG DOSE; MEMORY CONSOLIDATION; MEMORY DISORDER; NEUROSCIENCE; NONHUMAN; PATHOGENESIS; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOTHERAPY; REINFORCEMENT; SHORT TERM MEMORY; SINGLE DRUG DOSE; SOCIAL PHOBIA; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; CONDITIONING (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; FEAR; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; IMPLOSIVE THERAPY; MEMORY;

EID: 74849097702     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.janxdis.2009.10.011     Document Type: Article

References (83)

1. Aerni A., Traber R., Hock C., Roozendaal B., Schelling G., Papassotiropoulos A., et al. Low-dose cortisol for symptoms of posttraumatic stress disorder. American Journal of Psychiatry 161 (2004) 1488-1490
2. Baas J.M., Nugent M., Lissek S., Pine D.S., and Grillon C. Fear conditioning in virtual reality contexts: A new tool for the study of anxiety. Biological Psychiatry 55 (2004) 1056-1060
3. Barrett D., and Gonzales-Lima F. Behavioral effects of metyrapone on Pavlovian extinction. Neuroscience Letters 371 (2004) 91-96
4. Basoglu M., Marks I.M., Kilic C., Brewin C.R., and Swinson R.P. Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry 164 (1994) 652-659
5. Biondi M., and Picardi A. Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia. Psychotherapy and Psychosomatics 72 (2003) 110-111
6. Blechert J., Michael T., Vriends N., Margraf J., and Wilhelm F.H. Fear conditioning in posttraumatic stress disorder: Evidence for delayed extinction of autonomic, experiential, and behavioural responses. Behaviour Research and Therapy 45 (2007) 2019-2033
7. Bohus B., and Lissak K. Adrenocortical hormones and avoidance behaviour of rats. International Journal of Neuropharmacology 7 (1968) 301-306
8. Bouton M.E. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychological Bulletin 114 (1993) 80-99
9. Bouton M.E. Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction. Biological Psychiatry 52 (2002) 976-986
10. Bouton M.E., Kenney F.A., and Rosengard C. State-dependent fear extinction with two benzodiazepine tranquilizers. Behavioral Neuroscience 104 (1990) 44-55
11. Bouton M.E., and Swartzentruber D. Sources of relapse after extinction in Pavlovian and instrumental learning. Clinical Psychology Review 11 (1991) 123-140
12. Buchanan T.W., and Lovallo W.R. Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 26 (2001) 307-317
13. Buss C., Wolf O.T., Witt J., and Hellhammer D.H. Autobiographic memory impairment following acute cortisol administration. Psychoneuroendocrinology 29 (2004) 1093-1096
14. Cai W.H., Blundell J., Han J., Greene R.W., and Powell C.M. Postreactivation glucocorticoids impair recall of established fear memory. Journal of Neuroscience 26 (2006) 9560-9566
15. Centonze D., Siracusano A., Calabresi P., and Bernardi G. Removing pathogenic memories: A neurobiology of psychotherapy. Molecular Neurobiology 32 (2005) 123-132
16. Chambless D.L., and Ollendick T.H. Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology 52 (2001) 685-716
17. Coldwell S.E., Wilhelm F.H., Milgrom P., Prall C.W., Getz T., Spadafora A., Chiu J., LeRoux B., and Ramsay D.S. Combining alprazolam with systematic desensitization therapy for dental injection phobia. Journal of Anxiety Disorders 21 (2007) 871-887
18. Craske M.G., Kircanski K., Zelikowsky M., Mystkowski J., Chowdhury N., and Baker A. Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy 46 (2008) 5-27
19. Cuthbert B.N., Lang P.J., Strauss C., Drobes D., Patrick C.J., and Bradley M.M. The psychophysiology of anxiety disorder: Fear memory imagery. Psychophysiology 40 (2003) 407-422
20. de Quervain D.J., Aerni A., and Roozendaal B. Preventive effect of beta-adrenoceptor blockade on glucocorticoid-induced memory retrieval deficits. American Journal of Psychiatry 164 (2007) 967-969
21. de Quervain D.J., Aerni A., Schelling G., and Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Frontiers in Neuroendocrinology 30 (2009) 358-370
22. de Quervain D.J., Henke K., Aerni A., Treyer V., McGaugh J.L., Berthold T., et al. Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. European Journal of Neuroscience 17 (2003) 1296-1302
23. de Quervain D.J., and Margraf J. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: A novel therapeutic approach. European Journal of Pharmacology 583 (2008) 365-371
24. de Quervain D.J., Roozendaal B., and McGaugh J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394 (1998) 787-790
25. de Quervain D.J., Roozendaal B., Nitsch R.M., McGaugh J.L., and Hock C. Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nature Neuroscience 3 (2000) 313-314
26. Field A.P. Is conditioning a useful framework for understanding the development and treatment of phobias?. Clinical Psychology Review 26 (2006) 857-875
27. Flood J.F., Vidal D., Bennett E.L., Orme A.E., Vasquez S., and Jarvik M.E. Memory facilitating and anti-amnesic effects of corticosteroids. Pharmacology, Biochemistry, and Behavior 8 (1978) 81-87
28. Foa E.B., Franklin M.E., and Moser J. Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination?. Biological Psychiatry 52 (2002) 987-997
29. Foa E.B., Huppert J.D., and Cahill S.P. Emotional processing theory: An update. In: Rothbaum B.O. (Ed). Pathological anxiety emotional processing in etiology and treatment (2006), Guilford Press, New York 3-24
30. Foa E.B., and Kozak M.J. Emotional processing of fear: Exposure to corrective information. Psychological Bulletin 99 (1986) 20-35
31. Gould R.A., Buckminster S., Pollack M.H., Otto M.W., and Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clinical Psychology: Science and Practice 4 (1997) 291-306
32. Gould R.A., Otto M.W., and Pollack M.H. A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review 15 (1995) 819-844
33. Grillon C. Startle reactivity and anxiety disorders: Aversive conditioning, context, and neurobiology. Biological Psychiatry 52 (2002) 958-975
34. Grillon C., and Morgan III C.A. Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. Journal of Abnormal Psychology 108 (1999) 134-142
35. Het S., Ramlow G., and Wolf O.T. A meta-analytic review of the effects of acute cortisol administration on human memory. Psychoneuroendocrinology 30 (2005) 771-784
36. Kamphuis J.H., and Telch M.J. Effects of distraction and guided threat reappraisal on fear reduction during exposure-based treatments for specific fears. Behaviour Research and Therapy 38 (2000) 1163-1181
37. Kandel E.R. The molecular biology of memory storage: A dialogue between genes and synapses. Science 294 (2001) 1030-1038
38. Kovacs G.L., Telegdy G., and Lissak K. Dose-dependent action of corticosteroids on brain serotonin content and passive avoidance behavior. Hormones and Behavior 8 (1977) 155-165
39. Kuhlmann S., Kirschbaum C., and Wolf O.T. Effects of oral cortisol treatment in healthy young women on memory retrieval of negative and neutral words. Neurobiology of Learning and Memory 83 (2005) 158-162
40. Kuhlmann S., Piel M., and Wolf O.T. Impaired memory retrieval after psychosocial stress in healthy young men. Journal of Neuroscience 25 (2005) 2977-2982
41. Lang P.J. The cognitive psychophysiology of emotion: Fear and anxiety. In: Tuma A.H., and Maser J.D. (Eds). Anxiety and the anxiety disorders (1985), Lawrence Erlbaum Associates Inc., Hillsdale NJ England 131-170
42. Lang A.J., and Craske M.G. Manipulations of exposure-based therapy to reduce return of fear: A replication. Behaviour Research and Therapy 38 (2000) 1-12
43. LeDoux J.E. Emotion circuits in the brain. Annual Review of Neuroscience 23 (2000) 155-184
44. LeDoux J.E. Synaptic self: How our brains become who we are (2002), Viking, New York
45. Lee J.L., Milton A.L., and Everitt B.J. Reconsolidation and extinction of conditioned fear: Inhibition and potentiation. Journal of Neuroscience 26 (2006) 10051-10056
46. Michael T., Blechert J., Vriends N., Margraf J., and Wilhelm F.H. Fear conditioning in panic disorder: Enhanced resistance to extinction. Journal of Abnormal Psychology 116 (2007) 612-617
47. Michael T., and Ehlers A. Enhanced perceptual priming for neutral stimuli occurring in a traumatic context: Two experimental investigations. Behaviour Research and Therapy 45 (2007) 341-358
48. Michael T., Ehlers A., and Halligan S.L. Enhanced priming for trauma-related material in posttraumatic stress disorder. Emotion 5 (2005) 103-112
49. Michael T., Ehlers A., Halligan S.L., and Clark D.M. Unwanted memories of assault: What intrusion characteristics are associated with PTSD?. Behaviour Research and Therapy 43 (2005) 613-628
50. Milad M.R., and Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420 (2002) 70-74
51. Milad M.R., Rauch S.L., Pitman R.K., and Quirk G.J. Fear extinction in rats: Implications for human brain imaging and anxiety disorders. Biological Psychology 73 (2006) 61-71
52. Mineka S., and Cook M. Mechanisms involved in the observational conditioning of fear. Journal of Experimental Psychology: General 122 (1993) 23-38
53. Myers K.M., and Davis M. Behavioral and neural analysis of extinction. Neuron 36 (2002) 567-584
54. Mystokowski J.L., Mineka S., Vernon L.L., and Zinbarg R.E. Changes in caffeine states enhance return of fear in spider phobia. Journal of Consulting and Clinical Psychology 71 (2003) 243-250
55. Norberg M.M., Krystal J.H., and Tolin D.F. A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry 63 (2008) 1118-1126
56. Noyes Jr. R., Garvey M.J., Cook B., and Suelzer M. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry 148 (1991) 517-523
57. Noyes Jr. R., Garvey M.J., Cook B.L., and Samuelson L. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: Results of a naturalistic follow-up study. Journal of Clinical Psychiatry 50 (1989) 163-169
58. Öst L.G. Rapid treatment of specific phobias. In: Davey G.C.L. (Ed). Phobias: A handbook of theory, research, and treatment (1997), John Wiley, Chichester pp. XVI, 451
59. Otto M.W., Smits J.A.J., and Reese H.E. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice 12 (2005) 72-86
60. Overton D.A. State-dependent learning produced by depressant and atropine-like drugs. Psychopharmalogia (Berlin) 10 (1966) 6-31
61. Pavlov I.P.C., and Anrep G.V. Conditioned reflexes: An investigation of the physiological activity of the cerebral cortex (1927), Oxford University Press Humphrey Milford, Oxford London
62. Pedreira M.E., and Maldonado H. Protein synthesis subserves reconsolidation or extinction depending on reminder duration. Neuron 38 (2003) 863-869
63. Powers M.B., Smits J.A., Whitley D., Bystritsky A., and Telch M.J. The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology 76 (2008) 478-490
64. Przybyslawski J., and Sara S.J. Reconsolidation of memory after its reactivation. Behavioural Brain Research 84 (1997) 241-246
65. Quirk G.J., and Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33 (2008) 56-72
66. Rachman S., Craske M., Tallman K., and Solyom C. Does escape behavior strengthen agoraphobic avoidance? A replication. Behavior Therapy 17 (1986) 366-384
67. Rachman S.J. Fear and courage (1978), W. H. Freeman, San Francisco
68. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., Hodges L., and Davis M. Cognitive enhancers as adjuncts to psychotherapy: Use of d-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 61 (2004) 1136-1144
69. Roozendaal B. 1999 Curt P. Richter award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 25 (2000) 213-238
70. Roozendaal B., Griffith Q.K., Buranday J., de Quervain D.J., and McGaugh J.L. The hippocampus mediates glucocorticoid-induced impairment of spatial memory retrieval: Dependence on the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America, 100 (2003) 1328-1333
71. Roozendaal B., Hahn E.L., Nathan S.V., de Quervain D.J., and McGaugh J.L. Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. Journal of Neuroscience 24 (2004) 8161-8169
72. Rowe M.K., and Craske M.G. Effects of varied-stimulus exposure training on fear reduction and return of fear. Behaviour Research and Therapy 36 (1998) 719-734
73. Sajadi A.A., Samaei S.A., and Rashidy-Pour A. Blocking effects of intra-hippocampal naltrexone microinjections on glucocorticoid-induced impairment of spatial memory retrieval in rats. Neuropharmacology 52 (2007) 347-354
74. Sara S.J. Retrieval and reconsolidation: Toward a neurobiology of remembering. Learning & Memory 7 (2000) 73-84
75. Sloan T., and Telch M.J. The effects of safety-seeking behavior and guided threat reappraisal on fear reduction during exposure: An experimental investigation. Behaviour Research and Therapy 40 (2002) 235-251
76. Soravia L.M., Heinrichs M., Aerni A., Maroni C., Schelling G., Ehlert U., Roozendaal B., and de Quervain D.J. Glucocorticoids reduce phobic fear in humans. Proceedings of the National Academy of Sciences of the United States of America, 103 (2006) 5585-5590
77. Tsao J.C.I., and Craske M.G. Timing of treatment and return of fear: Effects of massed, uniform-, and expanding-spaced exposure schedules. Behavior Therapy 31 (2000) 479-497
78. Vervliet B. Learning and memory in conditioned fear extinction: Effects of d-cycloserine. Acta Psychologica 127 (2008) 601-613
79. Walker D.L., Ressler K.J., Lu K.T., and Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience 22 (2002) 2343-2351
80. Weingartner H. Human state dependent learning. In: Ho B.T., Richards III D.W., and Chute D.L. (Eds). Drug discrimination and state dependent learning (1978), Academic Press, New York 361-382
81. Wilhelm F.H., and Roth W.T. Acute and delayed effects of alprazolam on flight phobics during exposure. Behaviour Research and Therapy 35 (1997) 831-841
82. Wolf O.T., Convit A., McHugh P.F., Kandil E., Thorn E.L., De Santi S., McEwen B.S., and de Leon M.J. Cortisol differentially affects memory in young and elderly men. Behavioral Neuroscience 115 (2001) 1002-1011
83. Yang Y.L., Chao P.K., and Lu K.T. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 31 (2006) 912-924